PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Leaf extracts were evaluated for antihyperglycemic effects in healthy volunteers via oral glucose tolerance tests, as well as testing for alpha-glucosidase inhibition and insulin stimulation [PMID:25709220]
Ethanol extract significantly decreased total cholesterol, low density lipoprotein (LDL), triglyceride levels, and proinflammatory cytokines (IL-6) in a rat model [PMID:38948314]
Water extracts were investigated for the ability to reverse clusters of diseases in a fructose-induced rat model [PMID:31462242]
Crude alcoholic and base extracts obstructed amyloid-beta aggregation, with base extract inhibiting nucleation in SH-SY5Y cells [PMID:36235616]
Ethanolic extracts demonstrated antimicrobial potentials against Escherichia coli and Staphylococcus aureus [PMID:39141632]
Evidence summary
PubMed sources
- 1.PMID: 34673338 (2021) — Ultrasound-assisted encapsulation of Pandan (Pandanus amaryllifolius) extract. · Ultrasonics sonochemistry
- 2.PMID: 39053743 (2024) — Botany, phytochemistry, pharmacology, and applications of Pandanus amaryllifolius Roxb.: A review. · Fitoterapia
- 3.PMID: 25709220 (2015) — Antihyperglycemic effects of Pandanus amaryllifolius Roxb. leaf extract. · Pharmacognosy magazine
- 4.PMID: 30850030 (2019) — Recent Progress in the Chemistry of Pandanus Alkaloids. · The Alkaloids. Chemistry and biology
- 5.PMID: 36235616 (2022) — Pandanus amaryllifolius Exhibits In Vitro Anti-Amyloidogenic Activity and Promotes Neuroprotective Effects in Amyloid-β-Induced SH-SY5Y Cells.